HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Bonifazi, E. Articles by Novelli, G. Search for Related Content PubMed PubMed Citation Articles by Bonifazi, E. Articles by Novelli, G. Related Collections Molecular Diagnostics and Genetics

Use of RNA Fluorescence In Situ Hybridization in the Prenatal Molecular Diagnosis of Myotonic Dystrophy Type I

¹ Chairs of Human Genetics, Department of Biopathology and Diagnosing Imaging, Tor Vergata University of Rome, Rome, Italy;² Medical Genetics Unit, Policlinico Tor Vergata, Rome, Italy;³ Research Centre S. Pietro, Fatebenefratelli Hospital, Rome, Italy;

^aaddress correspondence to this author at: Cattedra di Genetica Umana, Dipartimento di Biopatologia e Diagnostica per Immagini, Facoltà di Medicina e Chirurgia - Ed. E-Nord, Università di Roma "Tor Vergata", Via Montpellier, 1, 00133 Rome, Italy; fax 39-6-20427313, e-mail emanuelabonifazi{at}yahoo.it

Abstract

Background: Myotonic dystrophy type 1 (DM1; OMIM #160900) is an autosomal-dominant genetic disorder with multisystemic clinical features associated with a CTG expansion in the 3' untranslated region of the DMPK gene on chromosome 19q13.3. A long-PCR protocol to detect the DM1 expansion is rapid, sensitive, and accurate, but interpretative limitations can occur when the expansion size exceeds the PCR amplification range and in cases of somatic mosaicism.

Methods: To overcome these problems, we used RNA fluorescence in situ hybridization (RNA-FISH) to study cultured cells derived from chorionic villus samples (CVS) with the DM1 mutation. The RNA-FISH method is designed to detect the distinctive DM1 cellular phenotype, characterized by the presence of nuclei with focal ribonuclear inclusions (foci) containing the DMPK expanded transcripts. We analyzed 6 CVS from DM1-predicted pregnancies and 6 CVS from DM1-negative pregnancies.

Results: In 4 DM1-predicted fetuses with a CTG expansion >200 CTG, varying numbers of ribonuclear inclusions were clearly visible in all cells. One case with a somatic mosaicism for the DMPK mutation showed 15% of cells with no nuclear foci. No nuclear signals were detected in all controls examined (n = 6) and in 1 DM1-positive sample with a CTG expansion <100 copies.

Conclusion: Nuclear foci, and therefore the DM1 mutation they are caused by, can be detected efficiently on interphase nuclei of trophoblast cells with RNA-FISH when the CTG expansion is >200 copies.

The following articles in journals at HighWire Press have cited this article:

				A. M. Blanco, L. Rausell, B. Aguado, M. Perez-Alonso, and R. Artero A FRET-based assay for characterization of alternative splicing events using peptide nucleic acid fluorescence in situ hybridization Nucleic Acids Res., June 26, 2009; (2009) gkp551v1. [Abstract] [Full Text] [PDF]